Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
小儿生血糖浆 (Children's Blood-building Syrup) is a traditional Chinese medicine (TCM) product developed and manufactured by Shenyang Dongxing Pharmaceutical Technology. Formulated as an oral syrup, it is specifically intended for pediatric use to support blood health and hematopoiesis (the formation of blood cellular components). As is characteristic of many TCM formulations, it likely contains a proprietary blend of herbal extracts traditionally used to "tonify" or nourish the blood. The product is approved and marketed in China as an over-the-counter (OTC) medication or health supplement. However, detailed pharmacological data, including specific active chemical constituents and molecular targets, are not publicly available in standard clinical databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 小儿生血糖浆.